載入...
Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19
Background/Purpose: Coronavirus disease 2019 (COVID-19) is associated with increased risk of acute ischemic stroke (AIS), however, there is a paucity of data regarding outcomes after administration of intravenous tissue plasminogen activator (IV tPA) for stroke in patients with COVID-19. Methods: We...
Na minha lista:
| 發表在: | J Stroke Cerebrovasc Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7383145/ https://ncbi.nlm.nih.gov/pubmed/33066885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105201 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|